263
Participants
Start Date
December 28, 2022
Primary Completion Date
February 25, 2040
Study Completion Date
February 25, 2040
Testing of hepatic AAV Vector integration
Evaluation of AAV vector integration in participants for whom a sample of liver has been obtained through biopsy or surgical resection when clinically indicated
RECRUITING
Royal Prince Alfred Hospital, Camperdown
RECRUITING
Weill Cornell Medical College-New York Presbyterian Hospital, New York
RECRUITING
The Childrens Hospital of Philadelphia Division of Hematology, Philadelphia
RECRUITING
USF Health Morsani Center For Advanced Healthcare, Tampa
RECRUITING
Ege Universitesi Hastanesi, Izmir
TERMINATED
Mississippi Center For Advanced Medicine, Madison
NOT_YET_RECRUITING
UCSF Outpatient Hematology Clinic, San Francisco
RECRUITING
UC Davis Health, Sacramento
RECRUITING
UC Davis Ambulatory Care Clinic, Sacramento
RECRUITING
UC Davis Hemophilia Treatment Center, Sacramento
RECRUITING
UC Davis Medical Center, Sacramento
NOT_YET_RECRUITING
Washington Institute for Coagulation, Seattle
Lead Sponsor
Pfizer
INDUSTRY